Status:
RECRUITING
A Cohort Study of Disease Prediction Model for High-risk Population With Bipolar Disorder
Lead Sponsor:
Shanghai Mental Health Center
Collaborating Sponsors:
Shanghai Mental Health Center, Hongkou District
Shanghai Mental Health Center, Xuhui District
Conditions:
High-risk
Bipolar Disorder
Eligibility:
All Genders
6-18 years
Brief Summary
Bipolar disorder (BD) is a serious, complicated, familial aggregation onset of mental illness, which has the characteristics of five-low and one-high, namely high prevalence, high recurrence rate, hig...
Eligibility Criteria
Inclusion Criteria:
- High-risk offsprings of parents with BD: Aged 6-18 yrs, both male and female. Offsprings and parents can sign the writtened informed consent form. At least one of parents was diagnosed with bipolar disorder by two or more senior psychiatric doctor.
- Atypical depression: Aged 6-18 yrs, both male and female. Patients and parents can sign the writtened informed consent form. Patients was diagnosed with atypical depression by two or more senior psychiatric doctor according to DSM-5. The disease phase and treatment regime are unrestricted.
- Health control: health individuals with age and gender matched with high-risk offsprings, no psychiatric family history.
Exclusion Criteria:
- High-risk offsprings of parents with BD: HCL-32 total score > 12. Individuals was diagnosed with BD or have symptoms of Axis I psychiatric disorder screened by K-SADS-PL . Individuals with severe physical disease, including kidney diseases, liver diseases or nervous system diseases etc.
- Atypical depression: HCL-32 total score > 12. Individuals was diagnosed with BD or have symptoms of Axis I psychiatric disorder screened by K-SADS-PL . Individuals with severe physical disease, including kidney diseases, liver diseases or nervous system diseases etc. Patients cormobid substance abuse or treated with MECT in recent half a year.
- Health control: Individuals with psychiatric family history, severe physical disease, including kidney diseases, liver diseases or nervous system diseases etc.
Key Trial Info
Start Date :
October 15 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
1200 Patients enrolled
Trial Details
Trial ID
NCT07031661
Start Date
October 15 2024
End Date
December 1 2025
Last Update
June 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shanghai Mental Health Center
Shanghai, Shanghai Municipality, China, 200030